Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001287920-26-000002
Filed / recorded
Mar 4, 2026, 9:56 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Elevance Health, Inc.
Issuer CIK
1156039
Ticker
ELV
Reporting person
Gail Boudreaux
Relationship
Director, Officer
Officer title
President and CEO
Security
Employee Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
63,818
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
63,818
Ownership form
Direct
Amendment
No
Footnotes from the filing
The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.
A board member of Elevance Health spent $870K of their very own money to buy Elevance Health shares. Their pile of Elevance Health shares grew by 470%.